1 / 3

Transradial Access Devices Market Size, Top Players, Trends in Upcoming Years

The preference for radial artery access for interventional operations is steadily rising around the world. The numerous advantages of this approach in transarterial chemoembolization, in cancer treatment, are fuelling the surge in the preference for transradial access devices. Moreover, the suitability of the procedure for a wide range of patients, such as morbidly obese patients, those suffering from severe peripheral vascular diseases, elderly (especially women), and those on oral anticoagulation medicines, and thus, at an extremely high risk of vascular access site bleeding, makes these devices highly sought-after.

Download Presentation

Transradial Access Devices Market Size, Top Players, Trends in Upcoming Years

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. What are key Factors Propelling the Surge of Global Transradial Access Devices Market? © P&S Intelligence. All rights reserved Page 1

  2. The preference for radial artery access for interventional operations is steadily rising around the world. The numerous advantages of this approach in transarterial chemoembolization, in cancer treatment, are fuelling the surge in the preference for transradial access devices. Moreover, the suitability of the procedure for a wide range of patients, such as morbidly obese patients, those suffering from severe peripheral vascular diseases, elderly (especially women), and those on oral anticoagulation medicines, and thus, at an extremely high risk of vascular access site bleeding, makes these devices highly sought- after. Moreover, the lower cost and favorable clinical outcomes of the transradial access procedure, as compared to the transfemoral approach, is expected to reduce healthcare expenses, especially in the emerging economies. Therefore, the global transradial access devices market is expected to witness an increase in its valuation from $14.9 billion in 2017 to $24.1 billion by 2023, at a CAGR of 8.4% during the forecast period (2018–2023). Transradial access simply means to snake a catheter or tube into the body via the radial artery, which runs through the forearm. Receive Sample Copy of this Report:https://www.psmarketresearch.com/market- analysis/transradial-access-devices-market/report-sample These devices are used in various procedures in the healthcare industry, such as drug administration, blood transfusion, diagnostics and testing, and fluid and nutrition administration. Amongst these, the demand for these devices was the highest for the drug administration application in 2017, mainly due to the wide-scale utilization of vascular-access devices for medication and treatment of cancer and several infections. As per the World Health Organization, 18.1 million people were diagnosed with the disease in 2018, and 9.6 million succumbed to it that year. Make an Enquiry before Purchase: https://www.psmarketresearch.com/send-enquiry?enquiry- url=transradial-access-devices-market The transradial access devices market is currently witnessing the rising number of collaborations of manufacturing companies with medical device preprocessing firms, shifting focus toward the development of robotic-assisted catheter systems, and increasing activities of the prominent companies in developing countries. In addition to this, the major companies are also launching innovative products in order to better serve customers and the medical cause. For instance, Teleflex Incorporated received the 510(k) clearance from the United States Food and Drug Administration (USFDA) in 2017 for its Spectre Guidewire and Twin-Pass Torque Dual Access Catheter. Therefore, it can be concluded that the demand for transradial access devices is set to skyrocket in the coming years, owing to the numerous advantages offered by them over snaking a catheter or tubing through the femoral vein in the thigh. © P&S Intelligence. All rights reserved Page 2

  3. Disclaimer: P&S Intelligence always keeps its customers’ interests at the core while carrying out research activities. P&S Intelligence ensures the reliability and accuracy of information and data provided in its market research publications. However, the information in publications is subject to fluctuations, as it is based on primary interviews of officials from various companies or organizations. P&S Intelligence is not responsible for any incorrect data provided by the key industry players of the concerned domain. The information or analysis in P&S Intelligence publications represents opinions based on research and should not be interpreted as statements of fact. Information in this report was believed to be correct at the time of publication, but cannot be guaranteed. P&S Intelligence does not endorse any product, service, or vendor depicted in its research publications. All intellectual properties, including trademarks and copyrights, belong to their respective owners and may be protected by copyright. Under no circumstance can these be reproduced in any form without prior written agreement of their owners. An order for market research report is intended for internal use of the company only and not for disclosure to third parties or any other publication in general. No service, report, or part thereof provided by P&S Intelligence can be reproduced, republished, resold, revealed, distributed, circulated, or sublicensed in any medium or form now realized or hereafter become realized, including but not limited to, all forms of optical-based media, magnetic, electronic, or digital, without a written permission from Prescient & Strategic Intelligence Pvt. Ltd. Kindly write to: enquiry@psmarketresearch.com B-13, Sector – 2, Noida, U.P. – 201301, INDIA Contact No: +91 120 4541 337 US/Canada Toll-Free: 1-888-778-7886 © P&S Intelligence. All rights reserved © P&S Intelligence. All rights reserved Page 3

More Related